Table 1.
Baseline characteristics of CKD stage 3–4, CKD stage 5-ESRD, and non-CKD groups.
Table 2.
Proton-pump inhibitors used in the out-patient clinic.
Fig 1.
Median values of total duration of PPI prescription during 2014–2015 by CKD groups (A), and duration prescribed at once by CKD groups(B). Fig 1A shows the CKD groups were prescribed significantly longer duration of PPIs than the non CKD group (p<0.001). Fig 1B shows the CKD stage5-ESRD group had significantly shorter duration of PPI prescribed at once than the other groups (p<0.001). †pair-wised comparisons were performed and p-value adjusted by bonfferoni correction.
Table 3.
Medicine prescribed with PPIs.
Fig 2.
Main departments prescribing PPIs.
The percent of prescriptions from the gastroenterology department gradually decreased, while percent of prescriptions from the nephrology department gradually increased as the eGFR decreased (Both p<0.001 in linear by linear association).OS, orthopedic surgery department; MN, Nephrology department; MC, Cardiology department; MG, Gastroenterology department; NR, Neurology department.